Lactate dehydrogenase production and release in a newly established human myeloma cell line

American Journal of Hematology

Volumn 66, Issue 4, 2001, Pages 267-273

  Hatakeyama, Nobuo ^a   Daibata, Masanori ^a   Nemoto, Yuiko ^a   Ohtsuki, Yuji ^a   Taguchi, Hirokuni ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cell line; Lactate dehydrogenase; Multiple myeloma

Indexed keywords

CELL SURFACE MARKER; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL STRUCTURE; CONTROLLED STUDY; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MYELOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; BONE MARROW; CULTURE MEDIA, CONDITIONED; ENZYME INDUCTION; FATAL OUTCOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; L-LACTATE DEHYDROGENASE; LEUKEMIA, T-CELL, ACUTE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0035095713     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1056     Document Type: Article

References (53)

1. A clinical staging system for multiple myeloma
2. Beta-2-microglobulin in myeloma: Optimal use for staging, prognosis and treatment - A prospective study of 160 patients
3. Beta 2 microglobulin in multiple myeloma
4. 2microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma
5. Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma
6. High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma
7. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma
8. Extensive extramedullary disease in myeloma: An uncommon variant with features of poor prognosis and dedifferentiation
9. A rapid banding technique for human chromosomes
10. Lactic dehydrogenase activity in blood
11. IgD myeloma presenting as a testicular tumor: Establishment and characterization of an IgD-secreting myeloma cell line
12. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia
13. Establishment of a T-cell line from human lymphosarcoma
14. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia
15. Establishment of a new peroxidase-positive human myeloid cell line, PL-21
16. 1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis
17. Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: Establishment of a novel cell line infected with HHV-6
18. An EBV-genome-negative cell line established from an American Burkitt lymphoma: Receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection
19. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma
20. Establishment and characterization of a thymic carcinoma cell line (Ty-82) carrying t(15;19)(q15;p13) chromosome
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line
23. Evolution of a gene: Multiple genes for LDH isozymes provide a model of the evolution of gene structure, function, and regulation
24. Nucleotide sequences of the cDNA and an intronless pseudogene for human lactate dehydrogenase-A isozyme
25. Structure of the human lactate dehydrogenase B gene
26. Lactic dehydrogenase in human neoplastic tissues
27. Relative ratios of mRNA molecules encoded by genes with homologous sequences using fluorescence-based single-strand conformation polymorphism analysis
28. Avoiding false positive with PCR
29. Establishment of a clonal cell line producing granulocyte colony-stimulating factor and parathyroid hormone-related protein from a lung cancer patient with leukocytosis and hypercalcemia
30. Multiple myeloma: Significance of plasmablastic subtype in morphological classification
31. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)
32. Characterization of adhesion molecules on human myeloma cell lines
33. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas
34. Serum lactic dehydrogenase (LDH) levels in acute leukemia; marked elevations in lymphoblastic leukemia
35. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma
36. Lactic dehydrogenase estimation in haematological malignancies
37. Identification of immature and mature myeloma cells in the bone marrow of human myelomas
38. Cloning and expression of the human interleukin-6 (BSF-2/INFβ 2) receptor
39. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis
40. Establishment of a CD45-positive immature plasma cell line from an aggressive multiple myeloma with high serum lactate dehydrogenase
41. Production of interleukin-1 by bone marrow myeloma cells
42. Production of interleukin 1β, a potent bone resorbing cytokine, by cultured human myeloma cells
43. Production of lymphotoxin, a boneresorbing cytokine, by cultured human myeloma cells
44. A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy
45. In vitro excess ammonia production in human myeloma cell lines
46. Establishment and characterization of an amylase-producing human myeloma cell line
47. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32)
48. Globulin-bound amylase: A cause of persistently elevated levels in serum
49. Macroamylasemia: A newly recognized cause for elevated serum amylase activity
50. Macromolecular lactic acid dehydrogenase: A cause of increased serum lactate dehydrogenase activity
51. Occurrence of enzymeimmunoglobulin complexes in chronic inflammatory bowel disease
52. Enzyme-linked immunoglobulin which binds both lactate dehydrogenase and hydroxybutyric dehydrogenase
53. Lactic dehydrogenase-immunoglobulin Gκ complex in a patients with idiopathic interstitial pneumonia